Drug Utilization Research (eBook)
John Wiley & Sons (Verlag)
978-1-118-94977-1 (ISBN)
Drug Utilization Research (DUR) is an eclectic scientific discipline, integrating descriptive and analytical methods for the quantification, understanding and evaluation of the processes of prescribing, dispensing and consumption of medicines and for the testing of interventions to enhance the quality of these processes. The discipline is closely related and linked mainly to the broader field of pharmacoepidemiology, but also to health outcomes research, pharmacovigilance and health economics.
Drug Utilization Research is a unique, practical guide to the assessment and evaluation of prescribing practices and to interventions to improve the use of medicines in populations. Edited by an international expert team from the International Society for Pharmacoepidemiology (ISPE), DUR is the only title to cover both the methodology and applications of drug utilization research and covers areas such as health policy, specific populations, therapeutics and adherence.
Drug Utilization Research (DUR) is an eclectic scientific discipline, integrating descriptive and analytical methods for the quantification, understanding and evaluation of the processes of prescribing, dispensing and consumption of medicines and for the testing of interventions to enhance the quality of these processes. The discipline is closely related and linked mainly to the broader field of pharmacoepidemiology, but also to health outcomes research, pharmacovigilance and health economics. Drug Utilization Research is a unique, practical guide to the assessment and evaluation of prescribing practices and to interventions to improve the use of medicines in populations. Edited by an international expert team from the International Society for Pharmacoepidemiology (ISPE), DUR is the only title to cover both the methodology and applications of drug utilization research and covers areas such as health policy, specific populations, therapeutics and adherence.
Monique Elseviers, Centre for Research and Innovation in Care, University of Antwerp, Belgium. Björn Wettermark, Associate Professor in Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden. Morten Andersen, Visiting Professor, Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden; Senior Physician at the Department of Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden; Senior Researcher at the Research Unit for General Practice, University of Southern Denmark, Denmark. Ria Benko, Associate Professor, Department of Clinical Pharmacy at the University of Szeged, Hungary. Marion Bennie, Professor of Pharmacy Practice, University of Strathclyde, UK; Chief Pharmaceutical Adviser, NHS National Services Scotland, UK. Brian Godman, Research Scientist, Karolinska Institutet, Stockholm, Sweden. Janet Krska, Professor of Clinical and Professional Pharmacy, Medway School of Pharmacy, Universities of Greenwich and Kent, UK. Elisabetta Poluzzi, Assistant Professor of Pharmacology, Department of Pharmacology, Faculty of Medicine, University of Bologna, Italy. Katja Taxis, Associate Professor of Pharmacotherapy and Clinical Pharmacy, University of Groningen, Netherlands. Vera Vlahovic-Palcevski, Professor, Department of Pharmacology, University of Rijeka Medical School, Croatia; Specialist in Clinical Pharmacology, University Hospital Rijeka, Croatia. Robert Vander Stichele, practicing family physician in Ghent, Belgium.
"Overall, this is a great resource for healthcare providers and a great learning tool for students. It is well written and includes many helpful figures and tables. The references to specific pages for more in-depth explanations of certain topics make this book very user friendly." (Doody Enterprises, 2016)
List of contributors
Niels Adriaenssens
Centre for General Practice Department of Primary and Interdisciplinary Care (ELIZA) and
Laboratory of Medical Microbiology
Vaccine & Infectious Disease Institute (VAXINFECTIO)
University of Antwerp
Belgium
Anna Birna Almarsdóttir
Clinical Pharmacology
Institute of Public Health
University of Southern Denmark
Denmark
Morten Andersen
Centre for Pharmacoepidemiology
Department of Medicine
Karolinska Institutet
Sweden
and
Research Unit of General Practice
Department of Public Health
University of Southern Denmark
Denmark
Indranil Bagchi
Pfizer
United States
Nadia Barozzi
Healthy4Life
Basel
Switzerland
Pia Bastholm Rahmner
Medical Management Centre
Department of Learning, Informatics, Management and Ethics
Karolinska Institutet
Sweden
Ria Benko
Department of Clinical Pharmacy
Faculty of Pharmacy
University of Szeged
Hungary
Kathleen Bennett
National Centre for Pharmacoeconomics
St James's Hospital
Ireland
Marion Bennie
Institute of Pharmacy and Biomedical Sciences
University of Strathclyde
Scotland
and
Information Services Scotland,
NHS National Services Scotland, United Kingdom
Ulf Bergman
Department of Clinical Pharmacology
Karolinska Institutet
Karolinska University Hospital
Sweden
Kevin Blake
Best Evidence Development Service
Human Medicines Research and Development Support Division
European Medicines Agency
United Kingdom
Hege Salvesen Blix
WHO Collaborating Centre for Drug Statistics Methodology
Department of Pharmacoepidemiology
Norwegian Institute of Public Health
Norway
Colin Bradley
Department of General Practice
University College Cork
Ireland
Nicky Britten
University of Exeter Medical School
United Kingdom
Stephen Byrne
School of Pharmacy, University College Cork
Ireland
Stephen Campbell
Centre for Primary Care
Institute of Population Health
and
Patient Safety Translational Research Centre
Institute of Population Health
University of Manchester
United Kingdom
Matthias Cavassini
Service of Infectious Disease
Centre hospitalier universitaire vaudois
and
University of Lausanne
Switzerland
Jennifer Celio
Community Pharmacy
School of Pharmaceutical Sciences
Universities of Geneva, University of Lausanne
Switzerland
and
Community Pharmacy
Department of Ambulatory Care & Community Medicine
University of Lausanne
Switzerland
Samuel Coenen
Department of Epidemiology and Social Medicine (ESOC)
Department of Primary and Interdisciplinary Care (ELIZA) and
Vaccine & Infectious Disease Institute (VAXINFECTIO)
University of Antwerp
Belgium
Shane Cullinan
University College Cork
Ireland
Petra Denig
Clinical Pharmacy and Pharmacology
University of Groningen, University Medical Center Groningen
The Netherlands
Fabrizio De Ponti
Pharmacology Unit
Department of Medical and Surgical Sciences
University of Bologna
Italy
Mirko Di Martino
Department of Epidemiology
Lazio Regional Health Service, Roma
Italy
Monique Elseviers
Centre for Research and Innovation in Care
Faculty of Medicine and Health Sciences
University of Antwerp
Belgium
Irene Eriksson
Centre for Pharmacoepidemiology
Department of Medicine
Karolinska Institutet
Sweden
and
Department of Healthcare Development
Stockholm County Council
Sweden
Andrew Gilbert
School of Pharmacy and Medical Sciences
University of South Australia
Australia
Brian Godman
Department of Laboratory Medicine
Karolinska Institutet
Sweden
and
Strathclyde Institute of Pharmacy and
Biomedical Sciences, University of Strathclyde,
Glasgow, United Kingdom
Jean-Pierre Grégoire
Faculty of Pharmacy
Laval University
Canada
and
Population Health and Optimal Health Practices
Research Unit
CHU de Québec Research Centre
Canada
Flora Haaijer-Ruskamp
Clinical Pharmacy and Pharmacology
University of Groningen, University Medical Center Groningen
The Netherlands
Jesper Hallas
Clinical Pharmacology
Institute of Public Health
University of Southern Denmark
Denmark
Donald Han
Pfizer
United States
Dorte Gilså Hansen
Research Unit of General Practice
Institute of Public Health
University of Southern Denmark
Denmark
Hanne Herborg
Pharmakon
Danish College of Pharmacy Practice
Denmark
Mikael Hoffmann
The NEPI Foundation
Linköping University
Sweden
Thomas Hofmarcher
Department of Economics
Lund University
Sweden
Kathleen Holloway
World Health Organization Regional Office for South-East Asia
India
Dyfrig Hughes
Centre for Health Economics & Medicines Evaluation
Bangor University
United Kingdom
Vu Thi Thu Huong
Pharmacy Department, E Hospital, Hanoi, Vietnam and Administration Medical Services, Ministry of Health, Hanoi
Vietnam
Luisa Ibáñez
Foundation of the Catalan Institute of Pharmacology (FICF)
Spain
Saira Jan
Department of Clinical Pharmacy Management
Horizon Blue Cross Blue Shield of New Jersey
United States and
Clinical Professor
Rutgers State University of New Jersey, Piscataway
New Jersey
United States
Bengt Jönsson
Stockholm School of Economics
Sweden
Roberta Joppi
Pharmaceutical Drug Department
Azienda Sanitaria Locale of Verona
Italy
Maarit Jaana Korhonen
Department of Pharmacology
Drug Development and Therapeutics
University of Turku
Finland
Janet Krska
Medway School of Pharmacy
Universities of Greenwich and Kent
United Kingdom
Xavier Kurz
Pharmacovigilance Division
European Medicines Agency
United Kingdom
Hye Young Kwon
Institute of Health and Environment
Seoul National University
South Korea
Laurent Laforest
PharmacoEpidemiology Lyon (PEL),
HESPER Unit, Claude-Bernard University-Lyon1
France
Irene Langner
AOK Research Institute (WIdO)
Germany
Hubert G.M. Leufkens
Division of Pharmacoepidemiology and Clinical
Pharmacology
Utrecht Institute for Pharmaceutical Sciences
Utrecht University
The Netherlands
Tatiana Chama Borges Luz
René Rachou Research Center
Oswaldo Cruz Foundation
Brazil
Sean MacBride-Stewart
Prescribing and Pharmacy Support Unit
NHS Greater Glasgow and Clyde
United Kingdom
Lorenzo G. Mantovani
Department of Statistics
School of Medicine
University of Milano
Italy
Jaana E. Martikainen
Research Department
Social Insurance Institution (Kela)
Finland
Maria Matuz
Department of Clinical Pharmacy
Faculty of Pharmacy
University of Szeged
Hungary
Frank May
Drug and Therapeutics Information Service,
Repatriation General Hospital, Daw Park,
South Australia
School of Pharmacy, Faculty of Health and
Behavioural Sciences, University of Queensland,
Australia
Giampiero Mazzaglia
Scientific and Regulatory Management Department
Human Medicines Evaluation Division
European Medicines Agency
United Kingdom
Stuart McTaggart
National Health Service for Scotland
United Kingdom
Juan Merlo
Unit for Social Epidemiology
Faculty of Medicine
Lund University
Skåne University Hospital
Sweden
Jocelyne Moisan
Faculty of Pharmacy
Laval University
Canada
and
Population Health and Optimal Health Practices
Research Unit
CHU de Québec Research Centre
Canada
Peter Mol
Medicines Evaluation Board
The Netherlands
and
Department of Clinical Pharmacy and Pharmacology
University Medical Centre Groningen
University of Groningen
The Netherlands
Luigi Naldi
Unità Complessa di Dermatologia
Azienda Ospedaliera Papa Giovanni XXIII and Centro Studi GISED (Italian Group for Epidemiologic Research in Dermatology)
Italy
Martin Neovius
Clinical Epidemiology Unit Department of Medicine
Karolinska Institutet
Sweden
Antje Neubert
Department of Paediatric and Adolescent Medicine
University Hospital Erlangen
Germany
Evalill Nilsson
The Research and Development Department of Local Health Care
Östergötland Region
Sweden
Hedvig Nordeng
Pharmaco-Epidemiology and Drug Safety Research Group
School of Pharmacy
University of...
| Erscheint lt. Verlag | 1.4.2016 |
|---|---|
| Sprache | englisch |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie |
| Schlagworte | Clinical Pharmacology & Therapeutics • drug utilization research methods medicine population International Society of Pharmacoepidemiology ISPE research • Klinische Pharmakologie u. Therapie • Medical Science • Medical Statistics & Epidemiology • Medizin • Medizinische Statistik u. Epidemiologie • Pharmacology & Pharmaceutical Medicine • pharmacovigilance health economics policy therapeutics • Pharmakologie u. Pharmazeutische Medizin |
| ISBN-10 | 1-118-94977-3 / 1118949773 |
| ISBN-13 | 978-1-118-94977-1 / 9781118949771 |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
EPUB (Adobe DRM)Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belletristik und Sachbüchern. Der Fließtext wird dynamisch an die Display- und Schriftgröße angepasst. Auch für mobile Lesegeräte ist EPUB daher gut geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich
